

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell aging (GO:0090344) | 5.26176970 |
| 2 | adenosine receptor signaling pathway (GO:0001973) | 5.15426974 |
| 3 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.09087827 |
| 4 | cellular response to ATP (GO:0071318) | 4.95863600 |
| 5 | gonadal mesoderm development (GO:0007506) | 4.83680076 |
| 6 | GDP-mannose metabolic process (GO:0019673) | 4.81321087 |
| 7 | adenine nucleotide transport (GO:0051503) | 4.65038464 |
| 8 | purine ribonucleotide transport (GO:0015868) | 4.50325686 |
| 9 | positive regulation of protein kinase C signaling (GO:0090037) | 4.46044391 |
| 10 | DNA strand renaturation (GO:0000733) | 4.39655440 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 4.29434324 |
| 12 | response to peptidoglycan (GO:0032494) | 4.25086780 |
| 13 | regulation of RIG-I signaling pathway (GO:0039535) | 4.22759045 |
| 14 | melanin biosynthetic process (GO:0042438) | 4.21807009 |
| 15 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.95867738 |
| 16 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.83930225 |
| 17 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.83559861 |
| 18 | UV protection (GO:0009650) | 3.81299784 |
| 19 | secondary metabolite biosynthetic process (GO:0044550) | 3.80923423 |
| 20 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.78785609 |
| 21 | oligosaccharide catabolic process (GO:0009313) | 3.75911103 |
| 22 | base-excision repair, AP site formation (GO:0006285) | 3.69980795 |
| 23 | negative regulation of interleukin-8 production (GO:0032717) | 3.68394353 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64923776 |
| 25 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.60537235 |
| 26 | melanin metabolic process (GO:0006582) | 3.59880795 |
| 27 | nucleoside transmembrane transport (GO:1901642) | 3.58556105 |
| 28 | purine nucleotide transport (GO:0015865) | 3.58305910 |
| 29 | protein retention in ER lumen (GO:0006621) | 3.43827454 |
| 30 | nucleotide transmembrane transport (GO:1901679) | 3.41025049 |
| 31 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.38958203 |
| 32 | positive regulation of T cell chemotaxis (GO:0010820) | 3.32106348 |
| 33 | regulation of T cell chemotaxis (GO:0010819) | 3.32106348 |
| 34 | regulation of interleukin-8 secretion (GO:2000482) | 3.27324183 |
| 35 | positive regulation of odontogenesis (GO:0042482) | 3.22938552 |
| 36 | mitotic cell cycle arrest (GO:0071850) | 3.17371870 |
| 37 | negative regulation of macrophage differentiation (GO:0045650) | 3.17147410 |
| 38 | purinergic receptor signaling pathway (GO:0035587) | 3.13989573 |
| 39 | response to ATP (GO:0033198) | 3.12406286 |
| 40 | granulocyte differentiation (GO:0030851) | 3.12040623 |
| 41 | regulation of cell aging (GO:0090342) | 3.10150161 |
| 42 | nucleoside transport (GO:0015858) | 3.09704390 |
| 43 | monocyte chemotaxis (GO:0002548) | 3.09001233 |
| 44 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.08518626 |
| 45 | negative regulation of necroptotic process (GO:0060546) | 3.00685929 |
| 46 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.97809586 |
| 47 | hyaluronan catabolic process (GO:0030214) | 2.95223014 |
| 48 | positive regulation of protein sumoylation (GO:0033235) | 2.92149688 |
| 49 | heme transport (GO:0015886) | 2.89879655 |
| 50 | rRNA modification (GO:0000154) | 2.87849238 |
| 51 | mannosylation (GO:0097502) | 2.85970737 |
| 52 | actin nucleation (GO:0045010) | 2.85888030 |
| 53 | grooming behavior (GO:0007625) | 2.84940528 |
| 54 | rRNA methylation (GO:0031167) | 2.84481223 |
| 55 | positive regulation of T cell migration (GO:2000406) | 2.84291696 |
| 56 | nucleoside salvage (GO:0043174) | 2.83938251 |
| 57 | iron coordination entity transport (GO:1901678) | 2.83806994 |
| 58 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.82952732 |
| 59 | regulation of T cell migration (GO:2000404) | 2.82758984 |
| 60 | lipopolysaccharide metabolic process (GO:0008653) | 2.82139886 |
| 61 | lens fiber cell differentiation (GO:0070306) | 2.81106779 |
| 62 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.80143326 |
| 63 | folic acid transport (GO:0015884) | 2.79684499 |
| 64 | detection of light stimulus involved in visual perception (GO:0050908) | 2.79549927 |
| 65 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.79549927 |
| 66 | nucleotide salvage (GO:0043173) | 2.78874009 |
| 67 | purine nucleotide salvage (GO:0032261) | 2.78682497 |
| 68 | negative regulation of defense response to virus (GO:0050687) | 2.75363485 |
| 69 | proline biosynthetic process (GO:0006561) | 2.72947815 |
| 70 | type B pancreatic cell proliferation (GO:0044342) | 2.71820829 |
| 71 | pyrimidine nucleoside salvage (GO:0043097) | 2.71560476 |
| 72 | pyrimidine-containing compound salvage (GO:0008655) | 2.71560476 |
| 73 | regulation of interferon-beta production (GO:0032648) | 2.71437573 |
| 74 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.64959729 |
| 75 | N-acetylneuraminate metabolic process (GO:0006054) | 2.64693951 |
| 76 | regulation of skeletal muscle contraction (GO:0014819) | 2.62721944 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.60980133 |
| 78 | response to parathyroid hormone (GO:0071107) | 2.60655698 |
| 79 | anatomical structure regression (GO:0060033) | 2.60340634 |
| 80 | positive regulation of protein homooligomerization (GO:0032464) | 2.59638723 |
| 81 | necroptotic process (GO:0070266) | 2.59150266 |
| 82 | cellular metabolic compound salvage (GO:0043094) | 2.58479771 |
| 83 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.57858651 |
| 84 | glycosphingolipid catabolic process (GO:0046479) | 2.57253540 |
| 85 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.54609812 |
| 86 | regulation of interleukin-8 production (GO:0032677) | 2.54208913 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 2.53651540 |
| 88 | positive regulation of lymphocyte migration (GO:2000403) | 2.51865748 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.50861030 |
| 90 | protein carboxylation (GO:0018214) | 2.50861030 |
| 91 | pentose-phosphate shunt (GO:0006098) | 2.49274638 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.48988915 |
| 93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48968923 |
| 94 | amino sugar catabolic process (GO:0046348) | 2.48958914 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.47651610 |
| 96 | negative regulation of chemokine production (GO:0032682) | 2.47625608 |
| 97 | positive regulation of T cell apoptotic process (GO:0070234) | 2.46452338 |
| 98 | negative regulation of metanephros development (GO:0072217) | 2.44050762 |
| 99 | regulation of monocyte differentiation (GO:0045655) | 2.43108857 |
| 100 | negative regulation of response to biotic stimulus (GO:0002832) | 2.43063977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.54102719 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.48796354 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.47945109 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.45085370 |
| 5 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.42787534 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.33180393 |
| 7 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13841783 |
| 8 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.07002627 |
| 9 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.05633408 |
| 10 | P68_20966046_ChIP-Seq_HELA_Human | 2.03808190 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.99738387 |
| 12 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.98001351 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.91971501 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.91161063 |
| 15 | MAF_26560356_Chip-Seq_TH2_Human | 1.88700198 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88220036 |
| 17 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.87196271 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.86500703 |
| 19 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.84543954 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.79612303 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79413524 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.77564019 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77544944 |
| 24 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.76215386 |
| 25 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.73398358 |
| 26 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.71681745 |
| 27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.70405065 |
| 28 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.67757975 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65964550 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65679415 |
| 31 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.62445697 |
| 32 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.61346518 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59905662 |
| 34 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.59412454 |
| 35 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.58815037 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57631904 |
| 37 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.52428528 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50351459 |
| 39 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.48459447 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.47072947 |
| 41 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.46815909 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45828811 |
| 43 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43351056 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40930156 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40820677 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40733025 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.40183928 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.39055855 |
| 49 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38692475 |
| 50 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.38313885 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38161629 |
| 52 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.37687969 |
| 53 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.36723521 |
| 54 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36323786 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35773832 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34999506 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34541302 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34502903 |
| 59 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.33954805 |
| 60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33592641 |
| 61 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.33556214 |
| 62 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33442802 |
| 63 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.33440224 |
| 64 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.33423581 |
| 65 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33395684 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29373014 |
| 67 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.27742835 |
| 68 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27476749 |
| 69 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.27466707 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.26379983 |
| 71 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.26276852 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25979652 |
| 73 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25804161 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25023271 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24875584 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24748890 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.24467840 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24204623 |
| 79 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.23742803 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22206520 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21581589 |
| 82 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20104687 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19012467 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18832138 |
| 85 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17868848 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16617624 |
| 87 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16585865 |
| 88 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15422302 |
| 89 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15139006 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13747928 |
| 91 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13011464 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12788141 |
| 93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12733227 |
| 94 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11354903 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10629088 |
| 96 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10474086 |
| 97 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09693532 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09338857 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08249099 |
| 100 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08139282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 5.18576873 |
| 2 | MP0005171_absent_coat_pigmentation | 4.45729314 |
| 3 | MP0003136_yellow_coat_color | 4.06860154 |
| 4 | MP0005174_abnormal_tail_pigmentation | 3.92342507 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.88572090 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.65039095 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.67290427 |
| 8 | MP0005083_abnormal_biliary_tract | 2.40231616 |
| 9 | MP0006082_CNS_inflammation | 2.23430039 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.22095353 |
| 11 | MP0000516_abnormal_urinary_system | 2.06742563 |
| 12 | MP0005367_renal/urinary_system_phenotyp | 2.06742563 |
| 13 | MP0009278_abnormal_bone_marrow | 2.02357239 |
| 14 | MP0000537_abnormal_urethra_morphology | 1.99861595 |
| 15 | MP0000750_abnormal_muscle_regeneration | 1.85742161 |
| 16 | MP0003303_peritoneal_inflammation | 1.84333968 |
| 17 | MP0003436_decreased_susceptibility_to | 1.75696466 |
| 18 | MP0000751_myopathy | 1.69379879 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 1.55419489 |
| 20 | MP0002419_abnormal_innate_immunity | 1.53266407 |
| 21 | MP0003656_abnormal_erythrocyte_physiolo | 1.50757860 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.50133919 |
| 23 | MP0003448_altered_tumor_morphology | 1.47485894 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.45475908 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.44875477 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.44875477 |
| 27 | MP0001348_abnormal_lacrimal_gland | 1.44716029 |
| 28 | MP0003315_abnormal_perineum_morphology | 1.43863941 |
| 29 | MP0001958_emphysema | 1.43420630 |
| 30 | MP0001661_extended_life_span | 1.41446370 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.40052385 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36750598 |
| 33 | MP0003075_altered_response_to | 1.34809016 |
| 34 | MP0002822_catalepsy | 1.34067433 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.33937724 |
| 36 | MP0001968_abnormal_touch/_nociception | 1.32977122 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.29890110 |
| 38 | MP0005025_abnormal_response_to | 1.28229009 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.25507772 |
| 40 | MP0003045_fibrosis | 1.24812990 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.24454860 |
| 42 | MP0003453_abnormal_keratinocyte_physiol | 1.20590670 |
| 43 | MP0009840_abnormal_foam_cell | 1.20562714 |
| 44 | MP0008260_abnormal_autophagy | 1.18033442 |
| 45 | MP0000685_abnormal_immune_system | 1.12091990 |
| 46 | MP0001756_abnormal_urination | 1.11945896 |
| 47 | MP0000343_altered_response_to | 1.11590188 |
| 48 | MP0005165_increased_susceptibility_to | 1.10206858 |
| 49 | MP0009764_decreased_sensitivity_to | 1.09337678 |
| 50 | MP0003091_abnormal_cell_migration | 1.07632555 |
| 51 | MP0009384_cardiac_valve_regurgitation | 1.06635983 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.06409935 |
| 53 | MP0001188_hyperpigmentation | 1.06376249 |
| 54 | MP0001853_heart_inflammation | 1.05051210 |
| 55 | MP0003011_delayed_dark_adaptation | 1.04196839 |
| 56 | MP0002405_respiratory_system_inflammati | 1.01901591 |
| 57 | MP0005330_cardiomyopathy | 1.00623669 |
| 58 | MP0005257_abnormal_intraocular_pressure | 0.99643959 |
| 59 | MP0009785_altered_susceptibility_to | 0.99220406 |
| 60 | MP0005310_abnormal_salivary_gland | 0.98604661 |
| 61 | MP0002723_abnormal_immune_serum | 0.98370551 |
| 62 | MP0002452_abnormal_antigen_presenting | 0.96429313 |
| 63 | MP0002638_abnormal_pupillary_reflex | 0.95946412 |
| 64 | MP0008004_abnormal_stomach_pH | 0.95604941 |
| 65 | MP0008469_abnormal_protein_level | 0.91196818 |
| 66 | MP0002736_abnormal_nociception_after | 0.90937011 |
| 67 | MP0001845_abnormal_inflammatory_respons | 0.88617046 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 0.88051905 |
| 69 | MP0001542_abnormal_bone_strength | 0.87998799 |
| 70 | MP0000858_altered_metastatic_potential | 0.87803353 |
| 71 | MP0005164_abnormal_response_to | 0.86106378 |
| 72 | MP0001905_abnormal_dopamine_level | 0.85516634 |
| 73 | MP0000747_muscle_weakness | 0.85508878 |
| 74 | MP0005000_abnormal_immune_tolerance | 0.82649131 |
| 75 | MP0000358_abnormal_cell_content/ | 0.79915853 |
| 76 | MP0005671_abnormal_response_to | 0.77794040 |
| 77 | MP0005464_abnormal_platelet_physiology | 0.77074952 |
| 78 | MP0005365_abnormal_bile_salt | 0.76849710 |
| 79 | MP0002420_abnormal_adaptive_immunity | 0.76671001 |
| 80 | MP0001819_abnormal_immune_cell | 0.75779287 |
| 81 | MP0002653_abnormal_ependyma_morphology | 0.75044565 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.74839532 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.74214813 |
| 84 | MP0009931_abnormal_skin_appearance | 0.72702144 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.72689706 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.72396942 |
| 87 | MP0005409_darkened_coat_color | 0.71512220 |
| 88 | MP0001790_abnormal_immune_system | 0.71161148 |
| 89 | MP0005387_immune_system_phenotype | 0.71161148 |
| 90 | MP0001664_abnormal_digestion | 0.71019617 |
| 91 | MP0003786_premature_aging | 0.70677247 |
| 92 | MP0004808_abnormal_hematopoietic_stem | 0.70079839 |
| 93 | MP0005023_abnormal_wound_healing | 0.69382828 |
| 94 | MP0004381_abnormal_hair_follicle | 0.67348951 |
| 95 | MP0010030_abnormal_orbit_morphology | 0.66150133 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.63957022 |
| 97 | MP0002429_abnormal_blood_cell | 0.63745427 |
| 98 | MP0005451_abnormal_body_composition | 0.63692622 |
| 99 | MP0001533_abnormal_skeleton_physiology | 0.62895102 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.61869482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 5.20883655 |
| 2 | Rib fusion (HP:0000902) | 5.09143340 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.15443532 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.15443532 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.15443532 |
| 6 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.10766315 |
| 7 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.10766315 |
| 8 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.10766315 |
| 9 | Ulnar bowing (HP:0003031) | 3.82296579 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.79876727 |
| 11 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.79876727 |
| 12 | Facial diplegia (HP:0001349) | 3.57535779 |
| 13 | Thin bony cortex (HP:0002753) | 3.52570383 |
| 14 | Male infertility (HP:0003251) | 3.51463789 |
| 15 | Akinesia (HP:0002304) | 3.51345137 |
| 16 | Attenuation of retinal blood vessels (HP:0007843) | 3.41152451 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.37557537 |
| 18 | Poikiloderma (HP:0001029) | 3.29907541 |
| 19 | Cervical subluxation (HP:0003308) | 3.26805581 |
| 20 | Vaginal fistula (HP:0004320) | 3.22003017 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.19603534 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.19060278 |
| 23 | Joint stiffness (HP:0001387) | 3.04734196 |
| 24 | Abnormal number of erythroid precursors (HP:0012131) | 2.98280923 |
| 25 | Rectal fistula (HP:0100590) | 2.91716280 |
| 26 | Rectovaginal fistula (HP:0000143) | 2.91716280 |
| 27 | Squamous cell carcinoma (HP:0002860) | 2.85145508 |
| 28 | Mesangial abnormality (HP:0001966) | 2.73455828 |
| 29 | Dyschromatopsia (HP:0007641) | 2.71544244 |
| 30 | Abnormality of the costochondral junction (HP:0000919) | 2.70411613 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 2.69595446 |
| 32 | Turricephaly (HP:0000262) | 2.65923148 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 2.63262570 |
| 34 | Coronal craniosynostosis (HP:0004440) | 2.62417974 |
| 35 | Intestinal fistula (HP:0100819) | 2.59038220 |
| 36 | Annular pancreas (HP:0001734) | 2.55717780 |
| 37 | Hypochromic anemia (HP:0001931) | 2.54783041 |
| 38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.54043754 |
| 39 | Facial hemangioma (HP:0000329) | 2.53194328 |
| 40 | Autoimmune thrombocytopenia (HP:0001973) | 2.50385023 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48762472 |
| 42 | Loss of speech (HP:0002371) | 2.48124583 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.47936825 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45529569 |
| 45 | Abnormality of placental membranes (HP:0011409) | 2.45060149 |
| 46 | Amniotic constriction ring (HP:0009775) | 2.45060149 |
| 47 | Anteriorly placed anus (HP:0001545) | 2.43888431 |
| 48 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.39026495 |
| 49 | Hemorrhage of the eye (HP:0011885) | 2.36356370 |
| 50 | Popliteal pterygium (HP:0009756) | 2.33873294 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 2.33481606 |
| 52 | Aplasia of the musculature (HP:0100854) | 2.32114241 |
| 53 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.30068356 |
| 54 | Epiphyseal stippling (HP:0010655) | 2.28466532 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.27853824 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.27498222 |
| 57 | Vacuolated lymphocytes (HP:0001922) | 2.23801757 |
| 58 | Type I transferrin isoform profile (HP:0003642) | 2.21277235 |
| 59 | Protrusio acetabuli (HP:0003179) | 2.20839934 |
| 60 | Joint hemorrhage (HP:0005261) | 2.20776534 |
| 61 | Diminished movement (HP:0002374) | 2.20001071 |
| 62 | Abnormal epiphyseal ossification (HP:0010656) | 2.18373355 |
| 63 | Retinal dysplasia (HP:0007973) | 2.14671213 |
| 64 | Delayed epiphyseal ossification (HP:0002663) | 2.10359806 |
| 65 | Increased IgM level (HP:0003496) | 2.09733146 |
| 66 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.06879748 |
| 67 | Abnormal protein glycosylation (HP:0012346) | 2.06879748 |
| 68 | Abnormal glycosylation (HP:0012345) | 2.06879748 |
| 69 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.06879748 |
| 70 | J-shaped sella turcica (HP:0002680) | 2.03222316 |
| 71 | Nonimmune hydrops fetalis (HP:0001790) | 2.02913984 |
| 72 | Cholelithiasis (HP:0001081) | 2.02794247 |
| 73 | Thrombocytosis (HP:0001894) | 2.01647399 |
| 74 | Increased serum ferritin (HP:0003281) | 2.00747282 |
| 75 | Bowing of the arm (HP:0006488) | 2.00090730 |
| 76 | Bowed forearm bones (HP:0003956) | 2.00090730 |
| 77 | Abnormal albumin level (HP:0012116) | 1.99617835 |
| 78 | Hypoalbuminemia (HP:0003073) | 1.99617835 |
| 79 | Petechiae (HP:0000967) | 1.98064180 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 1.91988954 |
| 81 | Global brain atrophy (HP:0002283) | 1.91528269 |
| 82 | Obstructive lung disease (HP:0006536) | 1.91027318 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 1.91027318 |
| 84 | Thoracic kyphosis (HP:0002942) | 1.90265107 |
| 85 | Choanal stenosis (HP:0000452) | 1.89089084 |
| 86 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87819467 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 1.87187878 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86636002 |
| 89 | Cheilitis (HP:0100825) | 1.84894576 |
| 90 | Zonular cataract (HP:0010920) | 1.83675598 |
| 91 | Ovoid vertebral bodies (HP:0003300) | 1.83137089 |
| 92 | Hypoplastic heart (HP:0001961) | 1.82262799 |
| 93 | Hepatosplenomegaly (HP:0001433) | 1.81275402 |
| 94 | Neonatal respiratory distress (HP:0002643) | 1.80664369 |
| 95 | Congenital stationary night blindness (HP:0007642) | 1.80524767 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.79284037 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 1.78800737 |
| 98 | Prolonged partial thromboplastin time (HP:0003645) | 1.78179540 |
| 99 | Severe visual impairment (HP:0001141) | 1.78179350 |
| 100 | Neoplasm of head and neck (HP:0012288) | 1.77560081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.56731424 |
| 2 | TESK2 | 4.04608984 |
| 3 | MAP2K3 | 3.64577663 |
| 4 | GRK6 | 2.89764844 |
| 5 | BCKDK | 2.83185701 |
| 6 | PIM2 | 2.78402798 |
| 7 | IRAK3 | 2.75928663 |
| 8 | ERN1 | 2.57703328 |
| 9 | BLK | 2.50803513 |
| 10 | TBK1 | 2.15073469 |
| 11 | TAOK2 | 2.08841537 |
| 12 | CCNB1 | 2.07377570 |
| 13 | MAP3K11 | 1.97157917 |
| 14 | NME2 | 1.94947373 |
| 15 | EPHB2 | 1.90768905 |
| 16 | VRK2 | 1.83321794 |
| 17 | EPHB1 | 1.74386236 |
| 18 | MUSK | 1.73255326 |
| 19 | TGFBR2 | 1.69816530 |
| 20 | PAK4 | 1.59629491 |
| 21 | MAP3K3 | 1.55953347 |
| 22 | ZAP70 | 1.51945487 |
| 23 | MAP4K1 | 1.48058174 |
| 24 | MAP2K7 | 1.45197129 |
| 25 | IKBKE | 1.43532258 |
| 26 | GRK7 | 1.31487095 |
| 27 | IRAK4 | 1.30990632 |
| 28 | WNK4 | 1.28404285 |
| 29 | DYRK1B | 1.26098243 |
| 30 | CDK19 | 1.23966958 |
| 31 | MAP2K6 | 1.21242565 |
| 32 | MAP2K4 | 1.21191210 |
| 33 | EPHA2 | 1.18715728 |
| 34 | CSK | 1.16620943 |
| 35 | ADRBK1 | 1.15945373 |
| 36 | FES | 1.14407828 |
| 37 | IRAK2 | 1.13368745 |
| 38 | KIT | 1.11236467 |
| 39 | TAOK1 | 1.09705795 |
| 40 | TAOK3 | 1.07954001 |
| 41 | PRKD2 | 1.07166182 |
| 42 | MAPK7 | 1.05420332 |
| 43 | TXK | 1.02436641 |
| 44 | SMG1 | 0.92807188 |
| 45 | TESK1 | 0.92506768 |
| 46 | MAP3K5 | 0.91096279 |
| 47 | KDR | 0.90010106 |
| 48 | ABL2 | 0.87604703 |
| 49 | IKBKB | 0.86266694 |
| 50 | SIK1 | 0.83812305 |
| 51 | MAP3K1 | 0.82664264 |
| 52 | SCYL2 | 0.79937288 |
| 53 | SIK2 | 0.76194534 |
| 54 | RPS6KC1 | 0.74995742 |
| 55 | RPS6KL1 | 0.74995742 |
| 56 | MAPK12 | 0.74178798 |
| 57 | MAP3K6 | 0.73345528 |
| 58 | ADRBK2 | 0.71885818 |
| 59 | DAPK1 | 0.71129450 |
| 60 | MYLK | 0.71050026 |
| 61 | TYK2 | 0.67916460 |
| 62 | DAPK2 | 0.66656664 |
| 63 | RPS6KA6 | 0.66232297 |
| 64 | FLT3 | 0.64674784 |
| 65 | DAPK3 | 0.63859914 |
| 66 | DDR2 | 0.59959257 |
| 67 | CSF1R | 0.59056352 |
| 68 | NEK9 | 0.58437841 |
| 69 | LYN | 0.58262588 |
| 70 | RPS6KA2 | 0.57393513 |
| 71 | PAK1 | 0.57330873 |
| 72 | STK16 | 0.54713457 |
| 73 | CDK4 | 0.51899324 |
| 74 | NEK2 | 0.50186572 |
| 75 | PRKD1 | 0.48801732 |
| 76 | BCR | 0.47518085 |
| 77 | CDK11A | 0.46848056 |
| 78 | MAP3K12 | 0.45687302 |
| 79 | PIK3CG | 0.44497066 |
| 80 | SYK | 0.43288707 |
| 81 | TRIB3 | 0.43206713 |
| 82 | PIM1 | 0.43140567 |
| 83 | MAP3K14 | 0.41142733 |
| 84 | CDK15 | 0.40507278 |
| 85 | IRAK1 | 0.40360277 |
| 86 | MST1R | 0.39500499 |
| 87 | AURKA | 0.38771972 |
| 88 | SIK3 | 0.37352598 |
| 89 | CDK18 | 0.36540938 |
| 90 | HIPK2 | 0.36517724 |
| 91 | PRKCD | 0.36367551 |
| 92 | LIMK1 | 0.36007025 |
| 93 | RAF1 | 0.35296907 |
| 94 | CDK14 | 0.34752495 |
| 95 | GSK3A | 0.34468141 |
| 96 | LRRK2 | 0.34258249 |
| 97 | PTK2B | 0.33480448 |
| 98 | DYRK3 | 0.33383184 |
| 99 | MAPK11 | 0.32829923 |
| 100 | JAK3 | 0.31394062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 5.49678317 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 5.10595236 |
| 3 | Sulfur relay system_Homo sapiens_hsa04122 | 4.57548717 |
| 4 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.44453679 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.73612662 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.68642473 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.53854590 |
| 8 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.51126060 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.50192904 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.42625864 |
| 11 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.37279720 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.31824211 |
| 13 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.20735147 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91899650 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.78606533 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.68412457 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41303245 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40261704 |
| 19 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.39700258 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.35954368 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.34764262 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.30068912 |
| 23 | Bladder cancer_Homo sapiens_hsa05219 | 1.29580520 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28385513 |
| 25 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.27819517 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18307451 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17831060 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.10455313 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09582440 |
| 30 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05734764 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05435640 |
| 32 | Ribosome_Homo sapiens_hsa03010 | 1.02257639 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.01275158 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00621165 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97322068 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97140674 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 0.94049459 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.93680066 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 0.91887639 |
| 40 | Malaria_Homo sapiens_hsa05144 | 0.87563418 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84399022 |
| 42 | Proteasome_Homo sapiens_hsa03050 | 0.83754171 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81358705 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 0.80954283 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 0.80563441 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78632540 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 0.75891255 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.74967726 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71478402 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68232617 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 0.66982739 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66578036 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.66360334 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65319110 |
| 55 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58852079 |
| 56 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.58083683 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57277518 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54522505 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54175520 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53735054 |
| 61 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53082263 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52353085 |
| 63 | Apoptosis_Homo sapiens_hsa04210 | 0.50850205 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49285798 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.49198080 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48557996 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46422186 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45445351 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.44199664 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41778211 |
| 71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41089335 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.39347947 |
| 73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.38535338 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37452422 |
| 75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36736412 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32681318 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.31916512 |
| 78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31541059 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30342830 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29656770 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28882349 |
| 82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28848960 |
| 83 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28650170 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28634049 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28570661 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.27542404 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.27279095 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.25930341 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25691233 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25288595 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24112736 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23384596 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19154450 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.18857112 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.17808317 |
| 96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.17555600 |
| 97 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16502174 |
| 98 | Allograft rejection_Homo sapiens_hsa05330 | 0.15536490 |
| 99 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.10723648 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09479619 |

